Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

14.77
+0.65004.60%
Post-market: 14.790.0199+0.13%19:51 EDT
Volume:2.61M
Turnover:37.45M
Market Cap:1.76B
PE:-19.89
High:14.80
Open:14.03
Low:13.70
Close:14.12
52wk High:17.75
52wk Low:8.03
Shares:119.20M
Float Shares:85.88M
Volume Ratio:1.18
T/O Rate:3.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7427
EPS(LYR):-1.1578
ROE:-57.33%
ROA:-13.46%
PB:12.67
PE(LYR):-12.76

Loading ...

BRIEF-Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Yesterday

Arcutis Biotherapeutics’ Earnings Call: Growth Amid Challenges

TIPRANKS
·
Aug 08

Stock Track | Arcutis Biotherapeutics Soars 6.71% Pre-market on Strong Q2 Results and FDA Approval

Stock Track
·
Aug 07

Stock Track | Arcutis Biotherapeutics Soars 6.71% on Strong Q2 Results, FDA Approval, and Analyst Optimism

Stock Track
·
Aug 07

Stock Track | Arcutis Biotherapeutics Surges 5.47% Pre-market Following Strong Q2 Results and FDA Approval

Stock Track
·
Aug 07

Mizuho Securities Keeps Their Buy Rating on Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
Aug 07

Stock Track | Arcutis Biotherapeutics Soars 6.12% on Strong Q2 Results and ZORYVE Growth

Stock Track
·
Aug 07

AI Play Arista Hits Record High, Joins 3 Best Stock Lists: Build Your Growth Stock Watchlist With These Just Updated Screens

Blockhead
·
Aug 07

Arcutis Biotherapeutics Q2 EPS $(0.13) Beats $(0.17) Estimate, Sales $81.504M Beat $72.753M Estimate

Benzinga
·
Aug 07

Arcutis Biotherapeutics Q2 Operating Expenses USD 96.115 Million

THOMSON REUTERS
·
Aug 07

Todd Watanabe, President and CEO, Reports Disposal of Common Shares in Arcutis Biotherapeutics Inc

Reuters
·
Aug 06

Exploring High Growth Tech Stocks In The US Market

Simply Wall St.
·
Jul 29

Arcutis Biotherapeutics (ARQT) Gets a Buy from Guggenheim

TIPRANKS
·
Jul 21

Jefferies Sticks to Its Buy Rating for Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
Jul 21

Patrick Burnett, Officer, Reports Disposal of Common Shares of Arcutis Biotherapeutics Inc

Reuters
·
Jul 15

Analysts Offer Insights on Healthcare Companies: Insulet (PODD) and Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
Jul 08

BRIEF-Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jul 04

Director Howard G. Welgus Reports Disposal of Arcutis Biotherapeutics Inc. Common Shares

Reuters
·
Jul 03

Arcutis Biotherapeutics' Zoryve Cream Receives Recommendation From American Academy of Dermatology

MT Newswires Live
·
Jun 26

Director Howard G. Welgus Reports Disposal of Common Shares in Arcutis Biotherapeutics Inc

Reuters
·
Jun 21